Annual ROA
8.89%
+1.93%+27.73%
31 December 2023
Summary:
Neurocrine Biosciences annual return on assets is currently 8.89%, with the most recent change of +1.93% (+27.73%) on 31 December 2023. During the last 3 years, it has fallen by -17.90% (-66.82%). NBIX annual ROA is now -66.82% below its all-time high of 26.79%, reached on 31 December 2020.NBIX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
11.76%
+0.81%+7.40%
30 September 2024
Summary:
Neurocrine Biosciences quarterly return on assets is currently 11.76%, with the most recent change of +0.81% (+7.40%) on 30 September 2024. Over the past year, it has increased by +4.02% (+51.94%). NBIX quarterly ROA is now -57.19% below its all-time high of 27.47%, reached on 30 September 2011.NBIX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.7% | +51.9% |
| 3 y3 years | -66.8% | -52.1% |
| 5 y5 years | +281.6% | +473.7% |
NBIX ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -66.8% | +88.8% | -52.1% | +1860.0% |
| 5 y | 5 years | -66.8% | +281.6% | -57.1% | +1860.0% |
| alltime | all time | -66.8% | +114.3% | -57.2% | +115.9% |
Neurocrine Biosciences ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 11.76%(+7.4%) |
| June 2024 | - | 10.95%(-13.8%) |
| Mar 2024 | - | 12.71%(+36.8%) |
| Dec 2023 | 8.89%(+27.7%) | 9.29%(+20.0%) |
| Sept 2023 | - | 7.74%(+0.8%) |
| June 2023 | - | 7.68%(+164.8%) |
| Mar 2023 | - | 2.90%(-59.7%) |
| Dec 2022 | 6.96%(+47.8%) | 7.20%(+157.1%) |
| Sept 2022 | - | 2.80%(+366.7%) |
| June 2022 | - | 0.60%(-83.1%) |
| Mar 2022 | - | 3.56%(-23.4%) |
| Dec 2021 | 4.71%(-82.4%) | 4.65%(-81.1%) |
| Sept 2021 | - | 24.55%(+15.2%) |
| June 2021 | - | 21.31%(-15.6%) |
| Mar 2021 | - | 25.25%(-8.0%) |
| Dec 2020 | 26.79%(+732.0%) | 27.44%(+303.5%) |
| Sept 2020 | - | 6.80%(-57.3%) |
| June 2020 | - | 15.92%(+5.9%) |
| Mar 2020 | - | 15.03%(+347.3%) |
| Dec 2019 | 3.22%(+38.2%) | 3.36%(+63.9%) |
| Sept 2019 | - | 2.05%(+9.0%) |
| June 2019 | - | 1.88%(-143.5%) |
| Mar 2019 | - | -4.32%(-280.0%) |
| Dec 2018 | 2.33%(-109.7%) | 2.40%(+101.7%) |
| Sept 2018 | - | 1.19%(-118.3%) |
| June 2018 | - | -6.51%(-57.8%) |
| Mar 2018 | - | -15.41%(-35.2%) |
| Dec 2017 | -24.11%(-28.2%) | -23.77%(-36.8%) |
| Sept 2017 | - | -37.61%(-23.4%) |
| June 2017 | - | -49.13%(-4.6%) |
| Mar 2017 | - | -51.51%(+55.4%) |
| Dec 2016 | -33.60%(+35.6%) | -33.15%(+18.9%) |
| Sept 2016 | - | -27.87%(+7.0%) |
| June 2016 | - | -26.04%(+20.0%) |
| Mar 2016 | - | -21.70%(+9.8%) |
| Dec 2015 | -24.78%(-18.6%) | -19.77%(+1.6%) |
| Sept 2015 | - | -19.45%(+16.3%) |
| June 2015 | - | -16.72%(+5.8%) |
| Mar 2015 | - | -15.81%(-37.1%) |
| Dec 2014 | -30.45%(+15.8%) | -25.14%(+9.5%) |
| Sept 2014 | - | -22.95%(+2.0%) |
| June 2014 | - | -22.50%(-5.9%) |
| Mar 2014 | - | -23.92%(-9.2%) |
| Dec 2013 | -26.29%(-973.4%) | -26.33%(+85.4%) |
| Sept 2013 | - | -14.20%(+50.7%) |
| June 2013 | - | -9.42%(+201.0%) |
| Mar 2013 | - | -3.13%(-217.2%) |
| Dec 2012 | 3.01%(-88.7%) | 2.67%(-251.7%) |
| Sept 2012 | - | -1.76%(-109.3%) |
| June 2012 | - | 18.94%(-15.0%) |
| Mar 2012 | - | 22.27%(-17.8%) |
| Dec 2011 | 26.57%(-459.1%) | 27.10%(-1.3%) |
| Sept 2011 | - | 27.47%(+265.8%) |
| June 2011 | - | 7.51%(-28.1%) |
| Mar 2011 | - | 10.44%(+435.4%) |
| Dec 2010 | -7.40% | 1.95%(-125.7%) |
| Sept 2010 | - | -7.59%(-63.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | -20.89%(-56.7%) |
| Mar 2010 | - | -48.26%(-14.4%) |
| Dec 2009 | -54.01%(+20.3%) | -56.36%(-7.7%) |
| Sept 2009 | - | -61.03%(+10.7%) |
| June 2009 | - | -55.11%(+13.3%) |
| Mar 2009 | - | -48.63%(+17.7%) |
| Dec 2008 | -44.89%(-27.9%) | -41.33%(-44.0%) |
| Sept 2008 | - | -73.83%(+5.2%) |
| June 2008 | - | -70.17%(+6.9%) |
| Mar 2008 | - | -65.64%(+7.0%) |
| Dec 2007 | -62.22%(+153.2%) | -61.35%(+137.1%) |
| Sept 2007 | - | -25.88%(-5.1%) |
| June 2007 | - | -27.28%(+5.9%) |
| Mar 2007 | - | -25.76%(+5.6%) |
| Dec 2006 | -24.57%(+454.6%) | -24.40%(-3.3%) |
| Sept 2006 | - | -25.22%(+134.8%) |
| June 2006 | - | -10.74%(+77.8%) |
| Mar 2006 | - | -6.04%(+34.2%) |
| Dec 2005 | -4.43%(-48.0%) | -4.50%(+20.6%) |
| Sept 2005 | - | -3.73%(-58.8%) |
| June 2005 | - | -9.05%(-7.1%) |
| Mar 2005 | - | -9.74%(+17.1%) |
| Dec 2004 | -8.52%(+15.6%) | -8.32%(+110.6%) |
| Sept 2004 | - | -3.95%(-31.8%) |
| June 2004 | - | -5.79%(-4.1%) |
| Mar 2004 | - | -6.04%(-15.8%) |
| Dec 2003 | -7.37%(-76.1%) | -7.17%(-63.2%) |
| Sept 2003 | - | -19.49%(-24.0%) |
| June 2003 | - | -25.63%(-12.8%) |
| Mar 2003 | - | -29.39%(-3.5%) |
| Dec 2002 | -30.85%(+122.4%) | -30.47%(+26.7%) |
| Sept 2002 | - | -24.05%(+34.1%) |
| June 2002 | - | -17.93%(+3.5%) |
| Mar 2002 | - | -17.33%(-1.7%) |
| Dec 2001 | -13.87%(-28.9%) | -17.63%(-11.5%) |
| Sept 2001 | - | -19.92%(-32.6%) |
| June 2001 | - | -29.57%(+13.9%) |
| Mar 2001 | - | -25.95%(+7.3%) |
| Dec 2000 | -19.52%(+10.2%) | -24.18%(+0.2%) |
| Sept 2000 | - | -24.13%(+12.9%) |
| June 2000 | - | -21.37%(-2.2%) |
| Mar 2000 | - | -21.84%(+4.8%) |
| Dec 1999 | -17.71%(-23.7%) | -20.83%(-20.3%) |
| Sept 1999 | - | -26.12%(+6.1%) |
| June 1999 | - | -24.62%(-11.0%) |
| Mar 1999 | - | -27.67%(+19.3%) |
| Dec 1998 | -23.20%(-486.7%) | -23.20%(+53.0%) |
| Sept 1998 | - | -15.16%(+56.1%) |
| June 1998 | - | -9.71%(+2674.3%) |
| Mar 1998 | - | -0.35%(-105.9%) |
| Dec 1997 | 6.00%(-20.6%) | 5.93%(-49.8%) |
| Sept 1997 | - | 11.82%(+11.2%) |
| June 1997 | - | 10.63%(-28.8%) |
| Mar 1997 | - | 14.94%(+59.3%) |
| Dec 1996 | 7.56% | 9.38%(+287.6%) |
| Sept 1996 | - | 2.42%(-31.8%) |
| June 1996 | - | 3.55% |
FAQ
- What is Neurocrine Biosciences annual return on assets?
- What is the all time high annual ROA for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual ROA year-on-year change?
- What is Neurocrine Biosciences quarterly return on assets?
- What is the all time high quarterly ROA for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly ROA year-on-year change?
What is Neurocrine Biosciences annual return on assets?
The current annual ROA of NBIX is 8.89%
What is the all time high annual ROA for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual return on assets is 26.79%
What is Neurocrine Biosciences annual ROA year-on-year change?
Over the past year, NBIX annual return on assets has changed by +1.93% (+27.73%)
What is Neurocrine Biosciences quarterly return on assets?
The current quarterly ROA of NBIX is 11.76%
What is the all time high quarterly ROA for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly return on assets is 27.47%
What is Neurocrine Biosciences quarterly ROA year-on-year change?
Over the past year, NBIX quarterly return on assets has changed by +4.02% (+51.94%)